thr

THR-0921 (CLX-0921) is a peroxisome proliferator-activated receptor (PPAR) agonist that can be used to study cardiovascular and metabolic diseases.

Fmoc-Gly-Thr(psi(Me,Me)pro)-OH is a polypeptide composed of glycine and threonine containing a (psi(Me,Me)pro) modification.

(D-Ser2)-Leu-Enkephalin-Thr is a delta selective agent of opioid receptor and shows analgesic effects.

Fmoc-Gln(Trt)-Thr(psi(Me,Me)pro)-OH is a dipeptide.

Ac-Ile-Glu-Thr-Asp-pNA is a caspase-8 substrate that undergoes enzymatic binding and cleavage specifically at the Ile-Glu-Thr-Asp (IETD) peptide sequence, resulting in the release of p-nitroalinide, which can be quantitatively measured using colorimetric detection at 405 nm as an indicator of caspase-8 enzyme activity.

Fmoc-Lys(Boc)-Thr(psi(Me,Me)pro)-OH is a dipeptide.

Fmoc-Asp(OtBu)-Thr(psi(Me,Me)pro)-OH is a dipeptide consisting of N-(9-fluorenylmethoxycarbonyl)-L-aspartic acid β-tert-butyl ester and a threonine analogue incorporating a non-native proline mimic with dimethyl substitution at the pseudopeptide bond.

Fmoc-Trp(Boc)-Thr(psi(Me,Me)pro)-OH is a dipeptide.

Fmoc-Glu(OtBu)-Thr(psi(Me,Me)pro)-OH is a dipeptide composed of Fmoc-protected glutamic acid with a tert-butyl ester side chain and threonine modified with a psi(Me,Me)pro residue.

Fmoc-Asn(Trt)-Thr(psi(Me,Me)pro)-OH is a dipeptide.

Thr101, also known as NOX Inhibitor VII, is a dose-dependent inhibitor of HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9. Thr101 is also a NOX inhibitor.

Fmoc-THR(GalNAc(Ac)3-α-D)-OH is a reagent for the preparation of a synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn antigen isomer which induces the antibody production against tumor cells. Fmoc-THR(GalNAc(Ac)3-α-D)-OH is a starting material to make trimeric MUC1 immunodominant motif antigen-based anti-cancer vaccine candidates.

Lys-arg-ala-lys-ala-lys-thr-thr-lys-lys-arg is a protein kinase C substrate.

GlcNAcβ(1-3)[GlcNAcβ(1-6)]GalNAc-α-Thr is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

GlcNAcβ(1-3)GalNAc-α-Thr is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

D-Threonine (H-D-Thr-OH) is a metabolite of Saccharomyces cerevisiae.

Threonyl-seryl-lysine has antigonadotropic activity isolated from bovine pineals.

O-Mannopyranosylthreonine is a bioactive chemical.

Gamma-Glutamylthreonine (γ-Glu-Thr) is a dipeptide formed by the linkage of glutamic acid and threonine through a peptide bond. It is a metabolic product catalyzed by γ-glutamyl transpeptidase and is associated with immune regulation. Gamma-Glutamylthreonine can be utilized in research related to inflammation-associated diseases.

Thr-Leu is a dipeptide composed of threonine and leucine that can be hydrolyzed in the peritoneal cavity to release its constituent amino acids, thereby increasing dialysate osmotic pressure, and it is used in kinetic and formulation studies of amino acid–based peritoneal dialysis fluids.

Proteinserine/threonine kinase (Ser/Thr protein kinase) is a biochemical reagent that serves as a biomaterial or organic compound, utilized in life science research.

Resmetirom (MGL-3196) is a THR-β agonist (EC50=0.21 μM), with high selectivity and oral activity. Resmetirom can be used in the research of non-cirrhotic and non-alcoholic steatohepatitis.

NH-3 is a potent orally active thyroid hormone receptor (THR) antagonist which exhibits reversible behavior, demonstrated by an IC 50 of 55 nM. Derived from the selective thyromi-metic GC-1, NH-3 effectively inhibits the binding of thyroid hormones to their respective receptors, resulting in hindered cofactor recruitment.

DS08210767 is a highly potent, orally bioavailable PTHR1 antagonist with an IC50 of 90 nM.